By Research Area
Hot products 
-
Mouse Anti-CTNND1 Recombinant Antibody (CBFYC-2414) (CBMAB-C2487-FY)
-
Mouse Anti-CD24 Recombinant Antibody (2Q1282) (CBMAB-C1624-CN)
-
Mouse Anti-CASQ1 Recombinant Antibody (CBFYC-0863) (CBMAB-C0918-FY)
-
Mouse Anti-BACE1 Recombinant Antibody (61-3E7) (CBMAB-1183-CN)
-
Rabbit Anti-CBL Recombinant Antibody (D4E10) (CBMAB-CP0149-LY)
-
Mouse Anti-BIRC3 Recombinant Antibody (315304) (CBMAB-1214-CN)
-
Mouse Anti-CCN2 Recombinant Antibody (CBFYC-2383) (CBMAB-C2456-FY)
-
Mouse Anti-ARHGDIA Recombinant Antibody (CBCNA-009) (CBMAB-R0415-CN)
-
Rat Anti-C5AR1 Recombinant Antibody (8D6) (CBMAB-C9139-LY)
-
Mouse Anti-CD24 Recombinant Antibody (HIS50) (CBMAB-C10123-LY)
-
Mouse Anti-2C TCR Recombinant Antibody (V2-1556) (CBMAB-0951-LY)
-
Mouse Anti-CARD11 Recombinant Antibody (CBFYC-0811) (CBMAB-C0866-FY)
-
Mouse Anti-ALB Recombinant Antibody (V2-363290) (CBMAB-S0173-CQ)
-
Mouse Anti-CD247 Recombinant Antibody (6B10.2) (CBMAB-C1583-YY)
-
Mouse Anti-CD19 Recombinant Antibody (CBXC-1224) (CBMAB-C1491-CQ)
-
Rat Anti-(1-5)-α-L-Arabinan Recombinant Antibody (V2-501861) (CBMAB-XB0003-YC)
-
Mouse Anti-AFDN Recombinant Antibody (V2-58751) (CBMAB-L0408-YJ)
-
Mouse Anti-AKT1 Recombinant Antibody (V2-180546) (CBMAB-A2070-YC)
-
Mouse Anti-ADGRL2 Recombinant Antibody (V2-58519) (CBMAB-L0166-YJ)
-
Mouse Anti-APOE Recombinant Antibody (A1) (CBMAB-0078CQ)
Glycobiology Research
Glycobiology investigates the structure, biosynthesis, and biological roles of glycans—complex carbohydrate chains covalently attached to proteins (glycoproteins) and lipids (glycolipids). These glycoconjugates are ubiquitous across all domains of life, forming a dynamic "sugar code" that regulates cellular communication, protein folding, immune recognition, and pathogen-host interactions. Unlike linear genetic information, glycans exhibit branching diversity, enabling them to serve as versatile molecular signals in health and disease.
Glycans modulate critical biological processes through precise interactions with lectins, antibodies, and enzymes. For instance, cell-surface glycoproteins govern leukocyte trafficking by binding selectins during inflammation, while glycosaminoglycans orchestrate extracellular matrix remodeling. Aberrant glycosylation—a hallmark of pathological states—is implicated in cancer metastasis, autoimmune disorders, and viral entry mechanisms. High-mannose glycans, for example, facilitate viral immune evasion by masking antigenic epitopes on viral envelopes.
Dysregulated glycan synthesis drives disease progression through altered cell adhesion, signaling, and immune surveillance. Tumor-associated carbohydrate antigens (TACAs), such as sialyl Lewis X, correlate with metastatic potential by promoting circulating tumor cell adhesion to vascular endothelium. Similarly, autoimmune conditions like lupus exhibit autoantibodies targeting glycosylated self-antigens. Advanced glycation end-products (AGEs), formed via non-enzymatic glycosylation, further contribute to diabetic complications and neurodegenerative pathologies.
Creative Biolabs provides rigorously validated antibodies targeting glycan epitopes, glycosyltransferases, and lectins, essential for elucidating glycan-mediated pathways. Our products are optimized for applications including flow cytometry, immunohistochemistry, and glycan array analysis, ensuring high specificity and batch-to-batch consistency. Leverage our expertise to dissect the sugar code's role in your disease models or therapeutic discovery pipelines.
Loading...
Compare
